Prostate Cancer Clinical Trials in New York

Showing 221-240 of 453 trials

Magnetic Resonance Imaging and Spectroscopy of the Prostate

NCT00590993

Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.

Prostate Cancer

Memorial Sloan Kettering Cancer Center1,005 participantsStarted Dec 2000

New York, New York, United States

COMPLETEDPhase 1/2< 1 mile

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

NCT01234025

The purpose of this study is to examine the safety, tolerability and progression-free survival of patients with Castrate-Resistant Prostate Cancer treated with ISIS EIF4E Rx in combination with docetaxel and prednisone.

Castrate-Resistant Prostate Cancer

Ionis Pharmaceuticals, Inc.113 participantsStarted Nov 2010

Fayetteville, Arkansas, United States • San Bernardino, California, United States • Fort Collins, Colorado, United States +35 more locations

Magnetic Resonance Imaging and Spectroscopy of the Prostate

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

Prostate Cancer Trials in Other Cities

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

A Study of FT-7051 in Men With MCRPC

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Prostvac in Patients With Biochemically Recurrent Prostate Cancer

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Improving Decision-Making for Low Health Literate Prostate CA Patients

Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients

Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer

Telomere Associated Variables (TAVs) in Prostate Cancer

Other Conditions in New York